51
Participants
Start Date
April 30, 2008
Primary Completion Date
August 31, 2010
Study Completion Date
December 31, 2012
Oxaliplatin, Capecitabine, Bevacizumab, Imatinib
"Dose level I:~Bevacizumab day 1: 7,5 mg/kg body weight Oxaliplatin day 1: 100 mg/m2 Capecitabine days 1-14 bid: 800 mg/m2 Imatinib days 1-21: 300 mg~Repeat on day 22.~Dose level II:~Bevacizumab day 1: 7,5 mg/kg body weight Oxaliplatin day 1: 130 mg/m2 Capecitabine days 1-14 bid: 1000 mg/m2 Imatinib days 1-21: 300 mg~Repeat on day 22."
Prosper-Hospital, Recklinghausen
Medical Clinic for Haematology and Oncology, Cologne
Johannes-Gutenberg-Universität Mainz, Mainz
Klinikum Mannheim, Mannheim
Städische Kliniken Esslingen, Esslingen am Neckar
Universitätsklinik Ulm, Ulm
Leopoldina Krankenhaus, Schweinfurt
Klinikum St. Georg gGmbH, Leipzig